Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2017 Apr 1;74(4):439–453. doi: 10.1097/QAI.0000000000001279

Table 1.

Study characteristics and smoking variables that included data presented by gender.

Reference Country Studya Sample Sizeb % Male Smoking Prevalence Nicotine Dependence CPD Smoking History Post-Diagnosis Smoking Motivation, Self-Efficacy, Beliefs about smoking Tobacco Products Quit Attempts Smoking Treatmentc
Collins et al., 200149 U.S. HCSUS 2864 77 X
Turner et al., 200177 U.S. PCHIS 548 88 X*
Mamary et al., 200246 U.S. -- 228 83 X X X
Gritz et al., 200443 U.S. -- 348 78 X* X
Neumann et al., 200445 Germany -- 309 78 X* X
Miguez-Burbarno et al., 200578 U.S. -- 521 58 X*
Benard et al., 200679 France ANRS CO3 Aquitaine Cohort 2036 75 X*
Elzi et al., 200668 Ireland -- 417 82 X
Glass et al., 200680 Switzerland SHCS 8033 69 X*
Mbulaiteye et al., 200681 U.S. NCI-AAC 2795 82 X
Benard et al., 200739 France ANRS CO3 Aquitaine Cohort 509 74 X X
Webb et al., 200735 U.S. -- 212 57 X*
Carr et al., 200882 U.S. SMART 4831 72 X*
De Socio et al., 200883 Italy SIMONE 1230 72 X*
Duval et al., 200884 France -- 593 70 X*
Jacobson et al., 200885 U.S. NHLS 379 75 X*
Murdoch et al., 200886 U.S. UNC-CFAR 300 67 X*
Desalu et al., 200987 Nigeria -- 312 43 X*
Jaquet et al., 200988 West Africae IeDEA 2920 29 X*
Peretti-Watel et al., 200952 France -- 254 79 X
Webb et al., 200989 U.S. -- 168 55 X*
Aboud et al., 201090 U.K. CREATE, HEART-UK 990 74 X*
Cahn et al., 201091 Latin Americaf RAPID II 4010 74 X*
Cui et al., 201048 Canada -- 119 79 X
Encrenaz et al., 201058 France ANRS CO3 Aquitaine Cohort 2223 77 X
Lifson et al., 201092 33 countriesg SMART 5472 73 X*
Tesoriero et al., 201040 U.S. -- 1094 62 X X X X
Amiya et al., 201153 Nepal -- 321 57 X* X
Brion et al., 201193 4 countriesh -- 775 60 X*
Collazos et al., 201194 Spain -- 782i 72 X*
Petoumenos et al., 201195 9 countriesj D:A:D 27136 78 X*
Pines et al., 201196 U.S. ASD 2108 80 X*
Shapiro et al., 201154 South Africa -- 150 66 X
Stewart et al., 201197 U.S. -- 289k 56 X*
Beachler et al., 201247 U.S. MACS, WIHS 379 (HIV), 266 (non-HIV) 57 X* X
Chander et al., 201298 U.S. -- 492 50 X*
Kristoffersen et al., 201299 Denmark -- 88 64 X*
Iliyasu et al., 2012100 Nigeria -- 296 72 X*
Moadel et al., 201264 U.S. -- 145 49 X
Shuter et al., 201256 U.S. -- 60 53 X
Villanti et al., 2012101 U.S. NHBS 669l 61 X*
Batista et al., 201344 Brazil -- 1815 62 X* X X X
Bryant et al., 2013102 U.S. -- 115 63 X*
Buchacz et al., 2013103 U.S. -- 3166 79 X
Cropsey et al., 201365 U.S. -- 40 48 X
Shirley et al., 2013104 U.S. -- 200 84 X*
Siconolfi et al., 2013105 U.S. ROAH 811m 74 X*
Tami-Maury et al., 201360 U.S. -- 474 70 X
Waweru et al., 2013106 South Africa -- 207 48 X*
Aichelburg et al., 2014107 Austria -- 305 73 X*
Chew et al., 201467 U.S. -- 774 56 X
Luo et al., 2014108 China -- 455 66 X*
Miguez-Barbano et al., 2014109 U.S. FILTERS 393 57 X*
Pacek, Latkin, Crum, et al., 2014110 U.S. BEACON 358n 62 X*
Pacek, Latkin et al., 201451 U.S. BEACON 267n 60 X X
Pacek et al., 2014111 U.S. NSDUH 349 75 X*
Shuter, Moadel, et al., 201455 U.S. -- 272 53 X
Shuter, Morales, et al., 201462 U.S. -- 138 55 X
Samperiz et al., 2014112 Spain -- 275 78 X*
Torres et al., 2014113 Brazil -- 2775 65 X*
Tron et al., 201442 France ANRS-Vespa2 3019 67 X* X
Vijayaraghavan et al., 201457 U.S. REACH 296 72 X
Ahlstrom et al., 2015114 Denmark -- 4515 75 X*
Cioe et al., 2015115 U.S. SUN 689 76 X*
Estrada et al., 2015116 Spain -- 860o,p 76 X*
Mdodo et al., 201537 U.S. MMP, NHIS 4217 (HIV), 27731 (GP) 71 (HIV), 48 (GP) X*
Moreno et al., 2015117 U.S. -- 203 76 X*
Nguyen et al., 2015118 Vietnam -- 1133 59 X*
O'Cleirigh et al., 2015119 U.S. -- 333 82 X
Rasmussen et al., 2015120 Denmark DHCS, CGPS 3233 (HIV), 12932 (GP) 79 X*
Schafer et al., 201559 Switzerland SHCS 4833 73 X
Shelley et al., 201563 U.S. -- 127 84 X
Zyambo et al., 2015121 U.S. UAB 1917 HCC 2464 75 X*
Browning et al., 201661 U.S. LHS 247 89 X
de Dios et al., 201666 U.S. -- 444 64 X
Marando et al., 2016122 Italy DHIVA 690 73 X*
Muyanja et al., 2016123 Uganda -- 250 32 X*
Shuter et al., 201641 U.S. -- 267 54 X X X X X X
Wang et al., 201650 China -- 2973 63 X

Key: ANRS, Agence Nationale de Recherches sur le Sida et les Hépatites Virales; ASD, Adult and Adolescent Spectrum of HIV Disease Project; BEACON, Being Active & Connected Study; BHC, Bristol HIV Cohort Study; CPD, cigarettes per day; CPGS, Copenhagen General Population Study; CREATE, Cardiovascular Risk Evaluation and Antiretroviral Therapy Study; D:A:D, Data Collection on Adverse Events of Anti-HIV Drugs Study; DHCS, Danish HIV Cohort Study; DHIVA, Dietitians in HIV Study; FILTERS, Florida International Liaison for Transdisciplinary and Educational Research on Smoking Study; GP, general population; HCSUS, HIV Cost and Services Utilization Study; HEART-UK, HEART-UK/Unilever CVD risk assessment study; IeDEA, International epidemiological Database to Evaluate AIDS; LHS, Lung HIV Study; MACS, Multicenter AIDS Cohort Study; MMP, Medical Monitoring Project; NCI-ACC, National Cancer Institute's AIDS Cancer Cohort Study; NHBS, National HIV Behavioral Surveillance System; NHIS, National Health Interview Survey; NHLS, Nutrition for Healthy Living Study; NSDUH, National Survey on Drug Use and Health; PCHIS, Pulmonary Complications of HIV Infection Study; RAPID II, Registry and Prospective Analysis of Patients Infected with HIV and Dyslipidemia; REACH, Research on Access to Care in the Homeless study; ROAH, Research on Older Adults with HIV; SHCS, Swiss HIV Cohort Study; SIMONE, SIndrome Metabolica ONE Study; SMART, Strategies for Management of Antiretroviral Therapy Study; SUN, Study to Understand the Natural History of HIV and AIDS in the Era of Effective Therapy Study; UAB 1917 HCC, University of Alabama 1917 HIV Clinic Cohort; U.K., United Kingdom; UNC-CFAR, University of North Carolina Center for AIDS Research (UNC-CFAR) HIV Clinical Cohort Study; U.S., United States; WIHS, Women Interagency HIV Study

*

Included in meta-analysis (i.e., presented data on current smoking by gender)

a

Name of parent study from which data were taken for the analyses if one was reported

b

Samples are of adults unless otherwise noted with superscripts

c

Including use of treatments, treatment adherence, treatment completion, and smoking outcomes

d

Adult factory workers

e

Benin, Côte d'Ivoire, Mali

f

Argentina, Brazil, Chile, Colombia, Ecuador, Peru, Venezuela

g

Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Denmark, Estonia, Finland, France, Germany, Greece, Ireland, Israel, Italy, Japan, Lithuania, Luxembourg, Morocco, New Zealand, Norway, Peru, Poland, Portugal, Russia, South Africa, Spain, Switzerland, Thailand, United Kingdom, United States, Uruguay

h

U.S., Puerto Rico, South Africa, Kenya

i

Australia, Denmark, The Netherlands, Belgium, Italy, U.K., Switzerland, France, U.S.

j

Co-infected with hepatitis C virus

k

Low-income African-American adults

l

Adults with past-year injection drug use

m

Adults age 50 years and older

n

Former or current injection drug users

o

Full sample n=895, smoking data were presented for 860 participants

p

Adults without past cardiovascular disease